Thomas U. Greiner
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
GLP-1 from the distal gut is dispensable for body weight and glucose regulation but slows small intestinal transit in female mice.
Journal: American journal of physiology. Endocrinology and metabolism
Published: December 10, 2025
Intestinal transit time phenotype is not transferred through gut microbiota transplantation.
Journal: PeerJ
Published: December 02, 2025
Enhanced plasma half-life and efficacy of engineered human albumin-fused GLP-1 despite enzymatic cleavage of its C-terminal end.
Journal: Communications biology
Published: March 26, 2024
Cold Exposure and Oral Delivery of GLP-1R Agonists by an Engineered Probiotic Yeast Strain Have Antiobesity Effects in Mice.
Journal: ACS synthetic biology
Published: October 12, 2023
Absence of gut microbiota reduces neonatal survival and exacerbates liver disease in Cyp2c70-deficient mice with a human-like bile acid composition.
Journal: Clinical science (London, England : 1979)
Published: May 11, 2023
Targeting the Gut in Obesity: Signals from the Inner Surface.
Journal: Metabolites
Published: November 13, 2021
BMP4 gene therapy enhances insulin sensitivity but not adipose tissue browning in obese mice.
Journal: Molecular metabolism
Published: October 30, 2019
Erratum: EGFR signalling controls cellular fate and pancreatic organogenesis by regulating apicobasal polarity.
Journal: Nature cell biology
Published: November 30, 2017
EGFR signalling controls cellular fate and pancreatic organogenesis by regulating apicobasal polarity.
Journal: Nature cell biology
Published: January 24, 2017
Microbially produced glucagon-like peptide 1 improves glucose tolerance in mice.
Journal: Molecular metabolism
Published: June 01, 2016
Microbial regulation of GLP-1 and L-cell biology.
Journal: Molecular metabolism
Published: May 02, 2016
Last Updated: 09/26/2026